Von Willebrand Disease: The Most Common Inherited Bleeding Disorder

Von Willebrand disease (VWD) is a genetic disorder that affects the blood's ability to clot, with approximately 1 in 100 people worldwide carrying the defective gene. The condition is named after Finnish physician Erik von Willebrand, who first described it in 1926. VWD is characterized by a deficiency or dysfunction of von Willebrand factor (VWF), a protein that plays a critical role in blood coagulation. According to the National Hemophilia Foundation, there are three main types of VWD: Type 1, Type 2, and Type 3, each with varying levels of severity. The disease can cause a range of symptoms, from mild to severe, including easy bruising, nosebleeds, and heavy menstrual bleeding. Researchers are working to develop new treatments, including gene therapy, which has shown promising results in clinical trials, with a 75% reduction in bleeding episodes reported in one study published in the New England Journal of Medicine.